You are here: Industry Insights > DCGI

News List

Biophore applies for DCGI approval for emergency use of Aviptadil to treat COVID-19 expresspharma
June 15, 2021
The company informed that it will be commencing commercial production immediately after the approval is received.
CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients expresspharma
June 15, 2021
Enrolment of patients has already begun at multiple sites across India and the trial is likely to be completed in the next 8-10 weeks.
Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India pharmaceutical-technology
June 08, 2021
The Drug Controller General of India (DCGI) has granted approval to the Serum Institute of India (SII) to produce Russia’s Covid-19 vaccine, Sputnik V, in the country.
SII gets approval from DCGI to produce Sputnik V vaccine in India expresspharma
June 07, 2021
The firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V at its licensed Hadapsar facility.
Zydus seeks DCGI nod for clinical trials of monoclonal antibodies cocktail to treat COVID-19 infection expresspharma
May 31, 2021
ZRC-3308 is a cocktail of two monoclonal antibodies targeting two unique epitopes on the spike protein of SARS-CoV-2.
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment expresspharma
May 20, 2021
As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with standard supportive care or standalone standard supportive care.
Virafin from Zydus Cadila priced at Rs 11,995 per dose expresspharma
May 12, 2021
The company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients, as per reports.
States must ensure special teams to prevent black marketing of drugs: Centre to SC expresspharma
May 11, 2021
All states must ensure special teams at different levels to “mercilessly clamp down” on hoarding and black marketing of drugs during the COVID-19 pandemic and send a clear message that “trading in human miseries” shall not be tolerated, the Centre has ...
DCGI nod for anti-COVID 19 drug developed by DRDO expresspharma
May 10, 2021
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
16.5 lakh vials of remdesivir to be allocated between 3rd and 9th May: Gowda expresspharma
May 07, 2021
Union Minister Gowda also stressed on the need to continuously monitor availability of other essential medicines and to check instances of black marketing and hoarding.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page